Chronos Archive seal
The Human Record

Booker T. Washington

Case HR-NI017 · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
April 5, 1856 – November 14, 1915
Synthetic DOB
1967-04-05
Index visit
2026-05-04 at age 59
Synthetic MRN
HR-NI017-SYN

Teaching objective: Recognize severe hypertension with kidney damage in a busy, hard-working adult, separate it from a hypertensive emergency, and manage hypertensive chronic kidney disease stage G3b A3 with maximum-dose renin-angiotensin blockade, an SGLT2 inhibitor, combination blood pressure therapy, and laboratory monitoring on the CMID schedule, while avoiding the biased attributions recorded in 1915.

Historical timeline

DateEventClaims
April 5, 1856Born into slavery on the Burroughs plantation, Franklin County, Virginia; the exact date is uncertain.CLM-0001, CLM-0002
1865Emancipated; moved with his family to Malden, West Virginia.CLM-0003
1876Mother, Jane, died in Malden.CLM-0003
July 4, 1881Opened Tuskegee Institute.CLM-0004
1911Beaten in New York City; head lacerations and a torn ear.CLM-0005
March 1915Sponsored National Negro Health Week.CLM-0004
November 2, 1915Admitted to the Rockefeller Institute hospital; blood pressure 220/150; Bright's disease diagnosed.CLM-0006, CLM-0007, CLM-0010
November 14, 1915Died at home in Tuskegee, Alabama.CLM-0008
2006Historical clinicopathological conference attributes his death to malignant hypertension with kidney failure.CLM-0009

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D Booker T. Washington was born into slavery on the James Burroughs plantation in Franklin County, Virginia, in 1856; the National Park Service timeline gives the date as April 5, 1856. confirmed Booker T. Washington supports
Washington Timeline supports
D Washington wrote in Up from Slavery (1901) that he was not sure of the exact date of his birth and estimated the year as 1858 or 1859; the April 5, 1856 date traces to a report by his brother John after his death and was adopted by the Tuskegee trustees.
The exact birth date is uncertain; the case uses the NPS date of April 5, 1856.
probable Black B. The Strange Case of Booker T. Washington's Birthday. Contingent Magazine, April 5, 2021 supports
D After emancipation in 1865 Washington moved with his mother, Jane, and his family to Malden, West Virginia, where he worked in the salt and coal mines; a National Park Service release gives his mother's death as 1876.
The source gives no cause of death; other accounts give 1874.
probable Washington Timeline supports
Footprints: Women Who Influenced Booker T. Washington (news release) supports
D Washington opened Tuskegee Institute in Tuskegee, Alabama, on July 4, 1881, at age 25, and led it for the rest of his life; in March 1915 he sponsored National Negro Health Week. confirmed Washington Timeline supports
Booker T. Washington supports
D In 1911 Washington was beaten in New York City and received two large gashes in his head and a torn ear, recovering without apparent sequelae; he had chronic indigestion, especially when traveling, and spent several days in 1911 at the Battle Creek Sanitarium.
From the annotated hospital record published with the 2006 clinicopathological conference.
probable The Death of Booker T. Washington (site bulletin) supports
D When Washington was admitted to the Rockefeller Institute hospital on November 2, 1915, his blood pressure was 220/150. He reported palpitations two weeks earlier, tiring quickly, frontal headaches one or two days out of every eight or nine, and slower thinking; the record also notes weight loss, failing vision, frequent urination, and avid thirst.
The documented anchor for the synthetic hypertension and kidney disease episode.
confirmed The Death of Booker T. Washington (site bulletin) supports
D In early November 1915, after several months of failing health, Dr. W. A. Bastedo in New York diagnosed Bright's disease, a contemporary term for kidney disease; Dr. Lucas G. Cole at the Rockefeller Institute hospital agreed, and Washington was moved to St. Luke's Hospital. confirmed The Death of Booker T. Washington (site bulletin) supports
D Washington traveled home from New York and died at Tuskegee on November 14, 1915, at age 59; the New York Times reported hardening of the arteries as the cause, and the National Park Service attributes his death to conditions related to high blood pressure.
Record the death as a fact without graphic detail.
confirmed The Death of Booker T. Washington (site bulletin) supports
Booker T. Washington supports
R A 2006 historical clinicopathological conference at the University of Maryland School of Medicine reviewed his hospital record and concluded that he presented with malignant hypertension that caused kidney failure.
A retrospective diagnosis; the modern problem list uses hypertensive kidney disease without asserting it as historical fact.
probable The Death of Booker T. Washington (site bulletin) supports
D A 1915 remark by Dr. Bastedo attributing the death partly to 'racial characteristics' was read by Washington's Chicago physician, Dr. George C. Hall, as implying syphilis; the hospital Wassermann test was negative, and the 2006 review did not support that explanation.
Teaching point about biased attribution in medical records; do not repeat the remark without this context.
confirmed The Death of Booker T. Washington (site bulletin) supports

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Severe hypertension with hypertensive kidney disease; synthetic modern diagnosis linked to the documented 1915 blood pressure of 220/150 active confirmed both_with_link CLM-0006, CLM-0009
S Chronic kidney disease stage G3b A3 (severely increased albuminuria), attributed to hypertensive nephrosclerosis active confirmed both_with_link CLM-0007, CLM-0009
S Hypertensive retinopathy, both eyes, without papilledema active confirmed active CLM-0006
S Mild anemia of chronic kidney disease, iron replete; monitor active confirmed active
S Hyperlipidemia active confirmed active
S Acute lumbar muscle strain after lifting, resolved without NSAIDs or imaging resolved confirmed active

Synthetic outcome measures

GradeDateMeasureResultCoding
S 2026-05-04 Sodium [Moles/volume] in Serum or Plasma 139 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-05-04 Potassium [Moles/volume] in Serum or Plasma 4.4 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-05-04 Carbon dioxide, total [Moles/volume] in Serum or Plasma 21 mmol/L (low)
Reference 22-29 mmol/L
http://loinc.org · 2028-9
S 2026-05-04 Urea nitrogen [Mass/volume] in Serum or Plasma 34 mg/dL (high)
Reference 6-24 mg/dL
http://loinc.org · 3094-0
S 2026-05-04 Creatinine [Mass/volume] in Serum or Plasma 2.1 mg/dL (high)
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 2026-05-04 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 36 mL/min/1.73 m² (low)
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-05-04 Glucose [Mass/volume] in Serum or Plasma 92 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 2026-05-04 Calcium [Mass/volume] in Serum or Plasma 9.1 mg/dL
Reference 8.6-10.3 mg/dL
http://loinc.org · 17861-6
S 2026-05-04 Phosphate [Mass/volume] in Serum or Plasma 4.2 mg/dL
Reference 2.5-4.5 mg/dL
http://loinc.org · 2777-1
S 2026-05-04 Parathyrin.intact [Mass/volume] in Serum or Plasma 92 pg/mL (high)
Reference 15-65 pg/mL
http://loinc.org · 2731-8
S 2026-05-04 Hemoglobin [Mass/volume] in Blood 12.6 g/dL (low)
Reference 13.2-16.6 g/dL
http://loinc.org · 718-7
S 2026-05-04 Ferritin [Mass/volume] in Serum or Plasma 210 ng/mL
Reference 30-400 ng/mL
http://loinc.org · 2276-4
S 2026-05-04 Iron saturation [Mass Fraction] in Serum or Plasma 26%
Reference 20-50%
http://loinc.org · 2502-3
S 2026-05-04 Thyrotropin [Units/volume] in Serum or Plasma 1.8 mIU/L
Reference 0.45-4.5 mIU/L
http://loinc.org · 3016-3
S 2026-05-04 Hemoglobin A1c/Hemoglobin.total in Blood 5.4%
Reference <=5.6%
http://loinc.org · 4548-4
S 2026-05-04 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 138 mg/dL (high)
Reference <=99 mg/dL
http://loinc.org · 13457-7
S 2026-05-04 Albumin/Creatinine [Mass Ratio] in Urine 820 mg/g (high)
Reference <=30 mg/g
http://loinc.org · 9318-7
S 2026-05-04 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 http://loinc.org · 44261-6
S 2026-05-11 Sodium [Moles/volume] in Serum or Plasma 138 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-05-11 Potassium [Moles/volume] in Serum or Plasma 4.6 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-05-11 Carbon dioxide, total [Moles/volume] in Serum or Plasma 22 mmol/L
Reference 22-29 mmol/L
http://loinc.org · 2028-9
S 2026-05-11 Urea nitrogen [Mass/volume] in Serum or Plasma 36 mg/dL (high)
Reference 6-24 mg/dL
http://loinc.org · 3094-0
S 2026-05-11 Creatinine [Mass/volume] in Serum or Plasma 2.2 mg/dL (high)
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 2026-05-11 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 34 mL/min/1.73 m² (low)
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-05-11 Glucose [Mass/volume] in Serum or Plasma 95 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 2026-06-01 Sodium [Moles/volume] in Serum or Plasma 137 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-06-01 Potassium [Moles/volume] in Serum or Plasma 4.9 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-06-01 Carbon dioxide, total [Moles/volume] in Serum or Plasma 22 mmol/L
Reference 22-29 mmol/L
http://loinc.org · 2028-9
S 2026-06-01 Urea nitrogen [Mass/volume] in Serum or Plasma 38 mg/dL (high)
Reference 6-24 mg/dL
http://loinc.org · 3094-0
S 2026-06-01 Creatinine [Mass/volume] in Serum or Plasma 2.4 mg/dL (high)
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 2026-06-01 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 30 mL/min/1.73 m² (low)
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-06-01 Glucose [Mass/volume] in Serum or Plasma 94 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 2026-06-29 Sodium [Moles/volume] in Serum or Plasma 135 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-06-29 Potassium [Moles/volume] in Serum or Plasma 4.3 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-06-29 Carbon dioxide, total [Moles/volume] in Serum or Plasma 23 mmol/L
Reference 22-29 mmol/L
http://loinc.org · 2028-9
S 2026-06-29 Urea nitrogen [Mass/volume] in Serum or Plasma 36 mg/dL (high)
Reference 6-24 mg/dL
http://loinc.org · 3094-0
S 2026-06-29 Creatinine [Mass/volume] in Serum or Plasma 2.4 mg/dL (high)
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 2026-06-29 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 30 mL/min/1.73 m² (low)
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-06-29 Glucose [Mass/volume] in Serum or Plasma 96 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 2026-06-29 Albumin/Creatinine [Mass Ratio] in Urine 360 mg/g (high)
Reference <=30 mg/g
http://loinc.org · 9318-7
S 2026-10-26 Sodium [Moles/volume] in Serum or Plasma 136 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-10-26 Potassium [Moles/volume] in Serum or Plasma 4.5 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-10-26 Carbon dioxide, total [Moles/volume] in Serum or Plasma 23 mmol/L
Reference 22-29 mmol/L
http://loinc.org · 2028-9
S 2026-10-26 Urea nitrogen [Mass/volume] in Serum or Plasma 34 mg/dL (high)
Reference 6-24 mg/dL
http://loinc.org · 3094-0
S 2026-10-26 Creatinine [Mass/volume] in Serum or Plasma 2.3 mg/dL (high)
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 2026-10-26 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 32 mL/min/1.73 m² (low)
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-10-26 Glucose [Mass/volume] in Serum or Plasma 93 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 2026-10-26 Calcium [Mass/volume] in Serum or Plasma 9.2 mg/dL
Reference 8.6-10.3 mg/dL
http://loinc.org · 17861-6
S 2026-10-26 Phosphate [Mass/volume] in Serum or Plasma 4 mg/dL
Reference 2.5-4.5 mg/dL
http://loinc.org · 2777-1
S 2026-10-26 Parathyrin.intact [Mass/volume] in Serum or Plasma 78 pg/mL (high)
Reference 15-65 pg/mL
http://loinc.org · 2731-8
S 2026-10-26 Hemoglobin [Mass/volume] in Blood 12.8 g/dL (low)
Reference 13.2-16.6 g/dL
http://loinc.org · 718-7
S 2026-10-26 Albumin/Creatinine [Mass Ratio] in Urine 240 mg/g (high)
Reference <=30 mg/g
http://loinc.org · 9318-7
S 2026-10-26 Kidney failure 2-year risk [Likelihood] by KFRE 6.5% http://loinc.org · 85624-5
S 2026-10-26 Kidney failure 5-year risk [Likelihood] by KFRE 18.8% http://loinc.org · 85625-2
S 2026-10-26 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 2 http://loinc.org · 44261-6
S 2026-05-11 Left ventricular Ejection fraction 60%
Reference 50-70%
http://loinc.org · 10230-1
S 2026-08-10 Sodium [Moles/volume] in Serum or Plasma 137 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-08-10 Potassium [Moles/volume] in Serum or Plasma 4.7 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-08-10 Carbon dioxide, total [Moles/volume] in Serum or Plasma 23 mmol/L
Reference 22-29 mmol/L
http://loinc.org · 2028-9
S 2026-08-10 Urea nitrogen [Mass/volume] in Serum or Plasma 37 mg/dL (high)
Reference 6-24 mg/dL
http://loinc.org · 3094-0
S 2026-08-10 Creatinine [Mass/volume] in Serum or Plasma 2.4 mg/dL (high)
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 2026-08-10 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 30 mL/min/1.73 m² (low)
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-08-10 Glucose [Mass/volume] in Serum or Plasma 94 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 2026-09-21 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 2 http://loinc.org · 44261-6
S 2026-09-21 Total score [AUDIT-C] 1 http://loinc.org · 75626-2

Synthetic vital signs

DateMeasureResultLOINCGrade
2026-05-04Body height170 cm8302-2S
2026-05-04Body weight71 kg29463-7S
2026-05-04Body mass index (BMI) [Ratio]24.6 kg/m239156-5S
2026-05-04Systolic blood pressure212 mm[Hg]8480-6S
2026-05-04Diastolic blood pressure128 mm[Hg]8462-4S
2026-05-04Heart rate88 /min8867-4S
2026-05-04Respiratory rate16 /min9279-1S
2026-05-04Body temperature36.8 Cel8310-5S
2026-05-04Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S
2026-05-11Body height170 cm8302-2S
2026-05-11Body weight71 kg29463-7S
2026-05-11Body mass index (BMI) [Ratio]24.6 kg/m239156-5S
2026-05-11Systolic blood pressure172 mm[Hg]8480-6S
2026-05-11Diastolic blood pressure104 mm[Hg]8462-4S
2026-05-11Heart rate82 /min8867-4S
2026-05-11Respiratory rate16 /min9279-1S
2026-05-11Body temperature36.7 Cel8310-5S
2026-05-11Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-06-01Body height170 cm8302-2S
2026-06-01Body weight70 kg29463-7S
2026-06-01Body mass index (BMI) [Ratio]24.2 kg/m239156-5S
2026-06-01Systolic blood pressure148 mm[Hg]8480-6S
2026-06-01Diastolic blood pressure92 mm[Hg]8462-4S
2026-06-01Heart rate78 /min8867-4S
2026-06-01Respiratory rate16 /min9279-1S
2026-06-01Body temperature36.8 Cel8310-5S
2026-06-01Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-06-29Body height170 cm8302-2S
2026-06-29Body weight70 kg29463-7S
2026-06-29Body mass index (BMI) [Ratio]24.2 kg/m239156-5S
2026-06-29Systolic blood pressure128 mm[Hg]8480-6S
2026-06-29Diastolic blood pressure80 mm[Hg]8462-4S
2026-06-29Heart rate74 /min8867-4S
2026-06-29Respiratory rate14 /min9279-1S
2026-06-29Body temperature36.7 Cel8310-5S
2026-06-29Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-10-26Body height170 cm8302-2S
2026-10-26Body weight70.5 kg29463-7S
2026-10-26Body mass index (BMI) [Ratio]24.4 kg/m239156-5S
2026-10-26Systolic blood pressure118 mm[Hg]8480-6S
2026-10-26Diastolic blood pressure76 mm[Hg]8462-4S
2026-10-26Heart rate72 /min8867-4S
2026-10-26Respiratory rate14 /min9279-1S
2026-10-26Body temperature36.6 Cel8310-5S
2026-10-26Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-08-10Body height170 cm8302-2S
2026-08-10Body weight70.3 kg29463-7S
2026-08-10Body mass index (BMI) [Ratio]24.3 kg/m239156-5S
2026-08-10Systolic blood pressure132 mm[Hg]8480-6S
2026-08-10Diastolic blood pressure82 mm[Hg]8462-4S
2026-08-10Heart rate80 /min8867-4S
2026-08-10Respiratory rate14 /min9279-1S
2026-08-10Body temperature36.7 Cel8310-5S
2026-08-10Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-09-21Body height170 cm8302-2S
2026-09-21Body weight70.4 kg29463-7S
2026-09-21Body mass index (BMI) [Ratio]24.4 kg/m239156-5S
2026-09-21Systolic blood pressure122 mm[Hg]8480-6S
2026-09-21Diastolic blood pressure76 mm[Hg]8462-4S
2026-09-21Heart rate72 /min8867-4S
2026-09-21Respiratory rate14 /min9279-1S
2026-09-21Body temperature36.6 Cel8310-5S
2026-09-21Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

Care-plan goals

GoalTarget dateStatusOutcome
Lower blood pressure below 130/80 within two months2026-06-29completedBlood pressure 128/80 on four medicines
Reach a standardized office systolic pressure below 120 when tolerated by the six-month review2026-10-26completedBlood pressure 118/76 without dizziness
Reduce the urine albumin-creatinine ratio by at least 30 percent by the six-month review2026-10-26completedUACR fell from 820 to 240 mg/g
Keep eGFR decline after starting therapy within 30 percent and stable thereafter2026-10-26completedeGFR 36 at baseline, 30 on full therapy, 32 at six months

Interventions

InterventionStatusGuideline
Treat severe hypertension without acute target-organ damage as an outpatient: start losartan and amlodipine together, check home blood pressure twice daily, and go to the emergency department for chest pain, shortness of breath, weakness, confusion, or vision losscompletedGL-HTN-2025
Nephrology referral for eGFR below 60 with severely increased albuminuria (UACR above 300 mg/g) and stage 2 hypertensioncompletedGL-KDIGO-CKD-2024, GL-CMID-2026
Titrate losartan to the maximum tolerated dose and add an SGLT2 inhibitor for CKD with UACR of at least 200 mg/g; accept a creatinine rise of up to 30 percentcompletedGL-KDIGO-CKD-2024, GL-KDIGO-BP-2021
Add chlorthalidone if blood pressure stays above target on two agents; avoid NSAIDs and review every medication dose for kidney functioncompletedGL-KDIGO-BP-2021, GL-HTN-2025
Check potassium and creatinine one to four weeks after each renin-angiotensin, SGLT2 inhibitor, or diuretic change; then eGFR and UACR about three times a year for G3b A3, hemoglobin at least yearly, and calcium, phosphate, and PTH every six to twelve months; recalculate the kidney failure risk yearlycompletedGL-CMID-2026, GL-KDIGO-CKD-2024
Moderate-intensity statin for an adult aged 50 or older with eGFR below 60; no routine repeat LDLcompletedGL-KDIGO-CKD-2024, GL-CMID-2026
Sodium below 2 g a day with a plan for meals while traveling; at least 150 minutes of activity a weekcompletedGL-KDIGO-CKD-2024, GL-HTN-2025
Annual dilated eye examination for hypertensive retinopathy; pneumococcal and hepatitis B vaccination for chronic kidney diseasecompletedGL-CMID-2026

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Booker T. Washington U.S. National Park Service, Tuskegee Institute National Historic Site government
SRC-0002 Washington Timeline U.S. National Park Service, Booker T. Washington National Monument government
SRC-0003 The Death of Booker T. Washington (site bulletin) U.S. National Park Service, Booker T. Washington National Monument government
SRC-0004 Black B. The Strange Case of Booker T. Washington's Birthday. Contingent Magazine, April 5, 2021 Contingent Magazine other
SRC-0005 Footprints: Women Who Influenced Booker T. Washington (news release) U.S. National Park Service, Booker T. Washington National Monument government
SRC-0006 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the outpatient handling of severe hypertension and the five-visit titration schedule.
provenance reviewnot_startedNPS biography, timeline, death bulletin, and news release logged; the 2006 conference is known only through the NPS bulletin; the birth date is uncertain.
safe messaging reviewnot_startedThe 1915 'racial characteristics' remark is flagged as sensitive and presented only with context; death recorded without graphic detail.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.